NoticiasCon ayuda de IA

Aluflexpack Introduces Recyclable Blister Packaging for the Pharma Industry

Aluflexpack launches 4∞ Form: a fully recyclable, lacquered aluminium blister pack for pharma industry.

Mrudula Kulkarni
Por Mrudula Kulkarni
Editor Gerente - Pharma Now
5 jul 2024Updated Jun 26, 2025 · 2 min de lectura
Aluflexpack Introduces Recyclable Blister Packaging for the Pharma Industry
https://www.aluflexpack.com/aluflexpack-ag-develops-4%E2%88%9E-form-an-innovative-and-sustainable-blister-pack/
Reportaje con ayuda de IA
Reviewed by Mrudula Kulkarni, Editor Gerente - Pharma Now

Aluflexpack, renowned for its premium flexible packaging solutions, has launched the 4∞ Form, a groundbreaking product designed specifically for the pharmaceutical industry.

The 4∞ Form blister pack is crafted entirely from lacquered aluminium, offering a sustainable alternative to conventional multimaterial packaging. This innovative design addresses the growing environmental concerns by providing a solution that is fully recyclable, unlike traditional blister packs which often pose significant recycling challenges.

Current blister pack solutions typically rely on a combination of materials such as polyamide nylon/aluminium/polyvinyl chloride (PVC, coldform) or PVC/polyvinylidene dichloride (thermoform). These complex material blends make recycling difficult, contributing to the increasing problem of packaging waste.

The 4∞ Form stands out due to its use of aluminium, a material known for its infinite recyclability. The name "4∞ Form" itself highlights this key advantage, as aluminium can be recycled endlessly without losing its properties. This makes it a particularly attractive option for the pharmaceutical industry, which is under pressure to reduce its environmental footprint.

TemasNews
Mrudula Kulkarni
Written by
Mrudula Kulkarni
Editor Gerente - Pharma Now

My international experience as a researcher in Taiwan for three years has equipped me with a global perspective, enabling me to create content that resonates with an international audience.



Discussion

Cargando la conversación…

Más de Pharma News

Todos los artículos →